GRAPHJET TECHNOLOGY (GTIJF): Nasdaq/NYSE listing notice — Energem Corp. receives Nasdaq delisting notice for failure to meet $50M market value requirement

GRAPHJET TECHNOLOGY

Received Nasdaq notice Nov 22, 2023 for non-compliance with Listing Rule 5450(b)(2)(A) because MVLS remained below $50M.
Company intends to timely request a hearing before the Nasdaq Panel to appeal the delisting determination.
A hearing request will stay suspension of trading; securities continue trading pending Panel decision.
No assurance that the Panel will grant continued listing; previous MVLS notice was received March 31, 2023.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GRAPHJET TECHNOLOGY received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: market value
Rules: 5450(b)(2)(A)

Exact text from the filing

November 22, 2023, Energem Corp., a special purpose acquisition company, incorporated as a Cayman Islands exempted company (the “Company”), received a notice (the “Notice”) from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) t hat the Company has not regained compliance with Listing Rule 5450(b)(2)(A) (the “Rule”) because the market value of its listed securities has remained below the minimum $50,000,000 required for continued listing. Accordingly, the Company’s securities will be delisted unless the Company requests an appeal of this determination as described below, tradi

View on SEC.gov

93 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

GRAPHJET TECHNOLOGY filing history →

Source: SEC EDGAR

accession 0001493152-23-043011

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.